Login| Sign Up| Help| Contact|

Patent Searching and Data

Document Type and Number:
Japanese Patent JP2004531454
Kind Code:
Obesity is a common clinical problem in most developed nations and is also rapidly becoming a major health concern in developing nations. Overweight individuals frequently suffer from several metabolic disorders such as insulin resistance, type 2 diabetes and dyslipidemia. This invention discloses proof of principle for the role PPARdelta (also known as beta) plays in the development of diet-induced obesity. In accordance with the present invention, a new method for treating obesity, insulin resistance and hyperlipidemia through administration of a pharmaceutical composition containing a chemical agent that antagonizes the function of PPARdelta(beta) protein, decreases PPARdelta(beta) gene expression and or transactivation of PPARdelta(beta) target gene expression is disclosed. This invention also proposes that obese, insulin resistant hyperlipidemic patients can be effectively treated with a combination of a PPARdelta(beta) antagonist with either an anti-diabetic agent or a lipid-lowering agent (or both).

Narayanan Hariharan
Application Number:
Publication Date:
October 14, 2004
Filing Date:
July 19, 2001
Export Citation:
Click for automatic bibliography generation   Help
International Classes:
A61K31/00; A61K31/192; A61K31/4439; A61K45/00; A61K45/06; A61P3/04; A61P3/06; A61P3/10; A61P5/50; G01N33/50; A61P19/02; G01N33/15; (IPC1-7): A61K45/00; A61K45/06; A61P3/04; A61P3/06; A61P3/10; A61P5/50; A61P19/02; G01N33/15; G01N33/50
Attorney, Agent or Firm:
Aoyama Aoi
Osamu Kawamiya
Kyousei Tamura
Minato Saito